“…In current clinical management guidelines, multifocality is not considered a stand-alone prognostic factor [4,9]. It has been reported in several large case series that multifocality is not related to recurrence or clinical outcomes in PTCs [10,[52][53][54]. On the other hand, some studies found a significant relationship between multifocality and adverse prognostic features, including higher tumor stage [25,28,42,44,55], higher risk for LNM [18,19,25,26,28,43,49,[55][56][57][58][59][60][61][62], and higher rate of recurrence [10,27,28,30,44,56,63].…”